A recommended offer values Humana at SEK 2.96 billion, with shareholders receiving cash, Ambea shares, and a CVR. The merger creates a leading Nordic care provider, expects SEK 120 million in annual synergies, and targets a 9.5% EBITDA margin by 2028. Regulatory approvals are pending.Based on Ambea…
A recommended offer values Humana at SEK 2.96 billion, with shareholders receiving cash, Ambea shares, and a CVR. The merger creates a leading Nordic care provider, expects SEK 120 million in annual synergies, and targets a 9.5% EBITDA margin by 2028. Regulatory approvals are pending.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
